Saturday, April 5, 2014

Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism

Although breast cancer frequently metastasizes to the bones and brain, rarely breast cancer patients may develop isolated liver metastasis. There is increasing data that anti-HER2 targeted therapy in conjunction with systemic chemotherapy may lead to increased rates of pathologic complete…

Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism




No comments:

Post a Comment